Seguir
Sean Rudd
Sean Rudd
Science For Life Laboratories, Karolinska Institutet
Dirección de correo verificada de scilifelab.se - Página principal
Título
Citado por
Citado por
Año
PrimPol bypasses UV photoproducts during eukaryotic chromosomal DNA replication
J Bianchi, SG Rudd, SK Jozwiakowski, LJ Bailey, V Soura, E Taylor, ...
Molecular cell 52 (4), 566-573, 2013
2882013
Validation and development of MTH1 inhibitors for treatment of cancer
UW Berglund, K Sanjiv, H Gad, C Kalderen, T Koolmeister, T Pham, ...
Annals of oncology 27 (12), 2275-2283, 2016
1392016
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
N Herold, SG Rudd, L Ljungblad, K Sanjiv, IH Myrberg, CBJ Paulin, ...
Nature medicine 23 (2), 256, 2017
1212017
Human PrimPol is a highly error-prone polymerase regulated by single-stranded DNA binding proteins
TA Guilliam, SK Jozwiakowski, A Ehlinger, RP Barnes, SG Rudd, ...
Nucleic acids research 43 (2), 1056-1068, 2015
1132015
Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
N Tsesmetzis, C Paulin, S Rudd, N Herold
Cancers 10 (7), 240, 2018
1072018
Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells
BDG Page, NCK Valerie, RHG Wright, O Wallner, R Isaksson, M Carter, ...
Nature communications 9 (1), 250, 2018
692018
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites
N Herold, SG Rudd, K Sanjiv, J Kutzner, J Bladh, CBJ Paulin, T Helleday, ...
Cell Cycle 16 (11), 1029-1038, 2017
662017
PPL2 translesion polymerase is essential for the completion of chromosomal DNA replication in the African Trypanosome
SG Rudd, L Glover, SK Jozwiakowski, D Horn, AJ Doherty
Molecular cell 52 (4), 554-565, 2013
662013
Pathways controlling dNTP pools to maintain genome stability
SG Rudd, NCK Valerie, T Helleday
DNA repair 44, 193-204, 2016
612016
PrimPol—A new polymerase on the block
SG Rudd, J Bianchi, AJ Doherty
Molecular & Cellular Oncology 1 (2), e960754, 2014
492014
With me or against me: Tumor suppressor and drug resistance activities of SAMHD1
N Herold, SG Rudd, K Sanjiv, J Kutzner, IH Myrberg, CBJ Paulin, ...
Experimental hematology 52, 32-39, 2017
482017
WT1 and its transcriptional cofactor BASP1 redirect the differentiation pathway of an established blood cell line
SJ Goodfellow, MR Rebello, E Toska, LAH Zeef, SG Rudd, KF Medler, ...
Biochemical Journal 435 (1), 113-125, 2011
472011
Ribonucleotide reductase inhibitors suppress SAMHD1 ara‐CTPase activity enhancing cytarabine efficacy
SG Rudd, N Tsesmetzis, K Sanjiv, CBJ Paulin, L Sandhow, J Kutzner, ...
EMBO Molecular Medicine, 2020
412020
Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens
GZ Rassidakis, N Herold, IH Myrberg, N Tsesmetzis, SG Rudd, JI Henter, ...
Blood cancer journal 8 (11), 98, 2018
362018
Cell Cycle Profiling Reveals Protein Oscillation, Phosphorylation, and Localization Dynamics
P Herr, J Boström, E Rullman, SG Rudd, M Vesterlund, J Lehtiö, ...
Molecular & Cellular Proteomics 19 (4), 608-623, 2020
282020
hMYH and hMTH1 cooperate for survival in mismatch repair defective T-cell acute lymphoblastic leukemia
S Eshtad, Z Mavajian, SG Rudd, T Visnes, J Boström, M Altun, T Helleday
Oncogenesis 5 (12), e275-e275, 2016
212016
MTH1 promotes mitotic progression to avoid oxidative DNA damage in cancer cells
K Sanjiv, SG Rudd, O Mortusewicz, A Stolz, N Amaral, L Brautigham, ...
Cancer Research 79 (13 Supplement), 105-105, 2019
20*2019
MTH1 promotes mitotic progression to avoid oxidative DNA damage in cancer cells
H Gad, O Mortusewicz, SG Rudd, A Stolz, N Amaral, L Brautigham, ...
BioRxiv, 575290, 2019
202019
MTH1 inhibitor TH588 disturbs mitotic progression and induces mitosis-dependent accumulation of genomic 8-oxodG
SG Rudd, H Gad, K Sanjiv, N Amaral, A Hagenkort, P Groth, CE Ström, ...
Cancer research 80 (17), 3530-3541, 2020
172020
SAMHD1 is a barrier to antimetabolite-based cancer therapies
SG Rudd, T Schaller, N Herold
Molecular & Cellular Oncology 4 (2), e1287554, 2017
172017
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20